概述

  • 产品名称Anti-HLA D+DR+DQ抗体[35]
  • 描述
    小鼠单克隆抗体[35] to HLA D+DR+DQ
  • 经测试应用适用于: IP, Flow Cyt, IHC-Frmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    Tumour fragments created by injecting VLM cells, (syngeneic simian virus 40 (SV40)-transformed cell line) into a BALB/c mouse.

  • 常规说明Recommended growth conditions: DMEM 5% FCS

性能

  • 形式Liquid
  • 存放说明Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • 存储溶液Preservative: None
    Constituents: PBS
  • Concentration information loading...
  • 纯度IgG fraction
  • 克隆单克隆
  • 克隆编号35
  • 骨髓瘤unknown
  • 同种型IgG3
  • 轻链类型unknown
  • 研究领域

应用

Our Abpromise guarantee covers the use of ab20177 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
IP Use at an assay dependent concentration.
Flow Cyt Use at an assay dependent concentration. ab91537-Mouse monoclonal IgG3, is suitable for use as an isotype control with this antibody.
IHC-Fr Use at an assay dependent concentration.

靶标

Anti-HLA D+DR+DQ antibody [35] (ab20177)参考文献

This product has been referenced in:
  • Allen CA & Hogg N Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes. Cancer Res 47:2919-23 (1987). Read more (PubMed: 3105871) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab20177.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"